As of Feb 12, 2025, the CLB stock has a PE ratio of 28.88. The calculation is based on the latest EPS of $0.58 and the stock price of $16.75 per share. The PE ratio currently is comparable to its last 4-quarter average.
The mean historical PE ratio of Core Laboratories N V over the last ten years is 48.22. The current 28.88 price-to-earnings ratio is 40% less than the historical average. Analyzing the last ten years, CLB's PE ratio reached its highest point in the Mar 2022 quarter at 143.77, with a price of $31.63 and an EPS of $0.22. The Dec 2019 quarter saw the lowest point at 16.38, with a price of $37.67 and an EPS of $2.3.
Maximum annual increase: 127.71% in 2009
Maximum annual decrease: -53.69% in 2023
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2023 | 22.35 | -53.69% | $17.66 | $0.79 |
2022 | 48.26 | -4.81% | $20.27 | $0.42 |
2021 | 50.7 | N/A | $22.31 | $0.44 |
2020 | N/A | N/A | $26.51 | -$2.2 |
2019 | 16.38 | -50.57% | $37.67 | $2.3 |
2018 | 33.14 | -43.13% | $59.66 | $1.8 |
2017 | 58.27 | -28.64% | $109.55 | $1.88 |
2016 | 81.66 | 102.03% | $120.04 | $1.47 |
2015 | 40.42 | 94.8% | $108.74 | $2.69 |
2014 | 20.75 | -42.3% | $120.34 | $5.8 |
2013 | 35.96 | 50.65% | $190.95 | $5.31 |
2012 | 23.87 | -16.42% | $109.31 | $4.58 |
2011 | 28.56 | 3.59% | $113.95 | $3.99 |
2010 | 27.57 | 15.31% | $89.05 | $3.23 |
2009 | 23.91 | 127.71% | $59.06 | $2.47 |
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
Sep 2024 | 31.95 | -18.12% | $18.53 | $0.58 |
Jun 2024 | 39.02 | 85.02% | $20.29 | $0.52 |
Mar 2024 | 21.09 | -5.64% | $17.08 | $0.81 |
Dec 2023 | 22.35 | -18.07% | $17.66 | $0.79 |
Sep 2023 | 27.28 | -0.26% | $24.01 | $0.88 |
Jun 2023 | 27.35 | -36.75% | $23.25 | $0.85 |
Mar 2023 | 43.24 | -10.4% | $22.05 | $0.51 |
Dec 2022 | 48.26 | 25.32% | $20.27 | $0.42 |
Sep 2022 | 38.51 | -61.12% | $13.48 | $0.35 |
Jun 2022 | 99.05 | -31.11% | $19.81 | $0.2 |
Mar 2022 | 143.77 | 183.57% | $31.63 | $0.22 |
Dec 2021 | 50.7 | 22.4% | $22.31 | $0.44 |
Sep 2021 | 41.42 | -23.44% | $27.75 | $0.67 |
Jun 2021 | 54.1 | -21.08% | $38.95 | $0.72 |
Mar 2021 | 68.55 | N/A | $28.79 | $0.42 |
The current PE ratio of CLB is under its 3, 5 and 10-year averages.
When compared to its peers FI and HLX, CLB's PE ratio is lower, but it is higher than SLB's and HAL's.
Stock name | PE ratio | Market cap |
---|---|---|
HAL Halliburton Co | 9.25 | $22.81B |
SLB Schlumberger Limited | 13.4 | $58.95B |
OII Oceaneering International Inc | 18.9 | $2.56B |
CLB Core Laboratories N V | 29.98 | $816.46M |
FI Fiserv, Inc. | 44.21 | $130.78B |
HLX Helix Energy Solutions Group Inc | 204.25 | $1.24B |
The price to earnings ratio for CLB stock as of Feb 12, 2025, stands at 28.88.
The average PE ratio for CLB stock over the past 3 years is 49.26.
The average PE ratio for CLB stock over the past 5 years is 50.44.
The highest quarterly PE ratio in the last ten years has been 143.77 and it was in the Mar 2022 quarter.
CLB's current price to earnings ratio is 40% below its 10-year historical average.
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months earnings per share(EPS). As of today (Feb 12, 2025), Core Laboratories N V's share price is $16.75. The company's earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $0.58. Therefore, Core Laboratories N V's price to earnings ratio for today is 28.88. PE RATIO(28.88) = STOCK PRICE($16.75) / TTM EPS($0.58)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.